Abstract:The natural history of COPD is complex, and the disease is best understood as a syndrome resulting from numerous interacting factors throughout the life cycle with smoking being the strongest inciting feature. Unfortunately, diagnosis is often delayed with several longitudinal cohort studies shedding light on the long 'preclinical' period of COPD. It is now accepted that individuals presenting with different COPD phenotypes may experience varying natural history of their disease. This includes its inception, early stages and progression to established disease. Several scenarios regarding lung function course are possible, but it may conceptually be helpful to distinguish between individuals with normal maximally attained lung function in their early adulthood who thereafter experience faster than normal FEV1 decline, and those who may achieve a lower than normal maximally attained lung function. This may be the main mechanism behind COPD in the latter group, as the decline in FEV1 during their adult life may be normal or only slightly faster than normal. Regardless of the FEV1 trajectory, continuous smoking is strongly associated with disease progression, development of structural lung disease and poor prognosis. In developing countries, factors such as exposure to biomass and sequelae after tuberculosis may lead to a more airway‐centred COPD phenotype than seen in smokers. Mechanistically, COPD is characterized by a combination of structural and inflammatory changes. It is unlikely that all patients share the same individual or combined mechanisms given the heterogeneity of resultant phenotypes. Lung explants, bronchial biopsies and other tissue studies have revealed important features. At the small airway level, progression of COPD is clinically imperceptible, and the pathological course of the disease is poorly described. Asthmatic features can further add confusion. However, the small airway epithelium is likely to represent a key focus of the disease, combining impaired subepithelial crosstalk and structural/inflammatory changes. Insufficient resolution of inflammatory processes may facilitate these changes. Pathologically, epithelial metaplasia, inversion of the goblet to ciliated cell ratio, enlargement of the submucosal glands and neutrophil and CD8‐T‐cell infiltration can be detected. Evidence of type 2 inflammation is gaining interest in the light of new therapeutic agents. Alarmin biology is a promising area that may permit control of inflammation and partial reversal of structural changes in COPD. Here, we review the latest work describing the development and progression of COPD with a focus on lung function trajectories, exacerbations and survival. We also review mechanisms focusing on epithelial changes associated with COPD and lack of resolution characterizing the underlying inflammatory processes.

Emergent structure-function relations in emphysema and asthma

Coupled Immunological and Biomechanical Model of Emphysema Progression

Bronchial Asthma, Airway Remodeling and Lung Fibrosis as Successive Steps of One Process

Predicting alveolar ventilation heterogeneity in pulmonary fibrosis using a non-uniform polyhedral spring network model

Eosinophils and tissue remodeling: Relevance to airway disease

A poroelastic model coupled to a fluid network with applications in lung modelling

Natural history and mechanisms of COPD

Airway Remodeling in Asthma: Mechanisms, Diagnosis, Treatment, and Future Directions

Respiratory healthcare by design: Computational approaches bringing respiratory precision and personalised medicine closer to bedside

What is the need and why is it time for innovative models for understanding lung repair and regeneration?

Endotyping Chronic Respiratory Diseases: T2 Inflammation in the United Airways Model

Health and Disease—Emergent States Resulting From Adaptive Social and Biological Network Interactions

Surfactant-Mediated Airway and Acinar Interactions in a Multi-Scale Model of a Healthy Lung

Airway remodelling in asthma and the epithelium: on the edge of a new era

Characterizing the viscoelasticity of extra- and intra-parenchymal lung bronchi

A Two-Way FSI Model for Pathologic Respiratory Processes with Precisely Structured and Flexible Upper Airway

Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: The one airway concept revisited

The Role of the Extracellular Matrix in the Pathogenesis and Treatment of Pulmonary Emphysema

Epithelial and endothelial cell plasticity in chronic obstructive pulmonary disease (COPD)

Bacterial Community Interactions During Chronic Respiratory Disease

Mechanical properties of the airway tree: heterogeneous and anisotropic pseudoelastic and viscoelastic tissue responses